Urotensin-II protects against cardiovascular events in patients with kidney disease

被引：0
|
作者：
不详
机构：
来源：
Nature Clinical Practice Nephrology | 2006年 / 2卷 / 7期
关键词：
D O I：
10.1038/ncpneph0196
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：350 / 350
相关论文
共 50 条
  • [1] Emerging roles of urotensin-II in cardiovascular disease
    Russell, FD
    PHARMACOLOGY & THERAPEUTICS, 2004, 103 (03) : 223 - 243
  • [2] Urotensin-II and cardiovascular remodeling
    Papadopoulos, Panayiota
    Bousette, Nicolas
    Giaid, Adel
    PEPTIDES, 2008, 29 (05) : 764 - 769
  • [3] Urotensin-II and cardiovascular diseases
    Bousette, Nicolas
    Giaid, Adel
    CURRENT HYPERTENSION REPORTS, 2006, 8 (06) : 479 - 483
  • [4] Urotensin-II and cardiovascular diseases
    Nicolas Bousette
    Adel Giaid
    Current Hypertension Reports, 2006, 8
  • [5] Determination of plasma urotensin-II in cats with chronic kidney disease.
    Elliott, J.
    Kleinz, M. J.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2008, 22 (03) : 799 - 800
  • [6] Urotensin-II: More Than a Mediator for Kidney
    Balat, Ayse
    Buyukcelik, Mithat
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2012, 2012
  • [7] Urotensin II is an inverse predictor of death and fatal cardiovascular events in chronic kidney disease
    Ravani, P.
    Tripepi, G.
    Pecchini, P.
    Mallamaci, F.
    Malberti, F.
    Zoccali, C.
    KIDNEY INTERNATIONAL, 2008, 73 (01) : 95 - 101
  • [8] CARDIOVASCULAR EFFECTS OF UROTENSIN-II IN ANESTHETIZED AND PITHED RATS
    GIBSON, A
    WALLACE, P
    BERN, HA
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 1986, 64 (03) : 435 - 439
  • [9] Urotensin-II and the cardiovascular system - the importance of developing modulators
    Doggrell, SA
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (05) : 479 - 487
  • [10] RELATIONSHIP BETWEEN UROTENSIN II AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Coban, Melahat
    Sozer, Yildiz Kilar
    ACTA MEDICA MEDITERRANEA, 2020, 36 (05): : 2929 - 2937
12345